Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-124437
Filing Date
2020-11-12
Accepted
2020-11-12 16:29:04
Documents
75
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2032966-1_10q.htm 10-Q 708632
2 EXHIBIT 31.1 tm2032966d1_ex31-1.htm EX-31.1 11146
3 EXHIBIT 31.2 tm2032966d1_ex31-2.htm EX-31.2 11135
4 EXHIBIT 32.1 tm2032966d1_ex32-1.htm EX-32.1 4657
5 EXHIBIT 32.2 tm2032966d1_ex32-2.htm EX-32.2 4584
  Complete submission text file 0001104659-20-124437.txt   7391594

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT tmbr-20200930.xml EX-101.INS 1961687
7 XBRL TAXONOMY EXTENSION SCHEMA tmbr-20200930.xsd EX-101.SCH 74106
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tmbr-20200930_cal.xml EX-101.CAL 55484
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tmbr-20200930_def.xml EX-101.DEF 274100
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmbr-20200930_lab.xml EX-101.LAB 546071
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmbr-20200930_pre.xml EX-101.PRE 458197
Mailing Address 50 TICE BLVD, SUITE A26 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BLVD, SUITE A26 WOODCLIFF LAKE NJ 07677 973-314-9570
Timber Pharmaceuticals, Inc. (Filer) CIK: 0001504167 (see all company filings)

EIN.: 593843182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37411 | Film No.: 201307174
SIC: 2834 Pharmaceutical Preparations